A detailed history of Td Asset Management Inc transactions in Immunome Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 394,618 shares of IMNM stock, worth $3.74 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
394,618
Previous 325,206 21.34%
Holding current value
$3.74 Million
Previous $3.93 Million 46.64%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$11.7 - $16.51 $812,120 - $1.15 Million
69,412 Added 21.34%
394,618 $5.77 Million
Q2 2024

Aug 02, 2024

BUY
$11.54 - $22.11 $454,675 - $871,134
39,400 Added 13.79%
325,206 $3.93 Million
Q1 2024

May 08, 2024

BUY
$11.01 - $27.34 $1.75 Million - $4.33 Million
158,526 Added 124.55%
285,806 $7.05 Million
Q3 2023

Oct 27, 2023

BUY
$6.17 - $9.16 $785,317 - $1.17 Million
127,280 New
127,280 $1.06 Million

Others Institutions Holding IMNM

About Immunome Inc.


  • Ticker IMNM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,127,400
  • Market Cap $115M
  • Description
  • Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...
More about IMNM
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.